[Long-term follow-up after hematopoietic stem cell transplantation].
Allogeneic hematopoietic stem cell recipients require specific long term follow-up. They are thus susceptible to develop late complications, either haematological or non haematological. The first year is characterized by the risk of chronic graft versus host disease and infections. Metabolic- and organ toxicity as well as potential secondary malignancy require very long-term follow-up. Prevention and early treatment by a multidisciplinary team are essential for the optimal management of these patients.
Robin
Marie
M
Service d'hématologie, greffes de la moelle osseuse, hôpital Saint-Louis, 75475 Paris Cedex 10, France.
Peffault de Latour
Régis
R
Socié
Gérard
G
D005500:Follow-Up Studies; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D014184:Transplantation, Homologous